TreeFrog Therapeutics
TreeFrog Therapeutics provides access to cell therapies for patients. The company has developed C-StemTM, a high-throughput cell encapsulation technology allowing for the mass-production and differentiation of stem cells in industrial bioreactors. This proprietary technology platform provides an end-to-end and scalable solution that dramatically improves the quality of therapeutic cells and reduce production costs. The company was founded in 2018 and is headquartered in France.
Last updated on
About TreeFrog Therapeutics
Founded
2018Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$87MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
PessacState
Nouvelle-AquitaineCountry
FranceTreeFrog Therapeutics
Find your buyer within TreeFrog Therapeutics
Tech Stack (83)
Communications
Programming Languages And Frameworks
Collaboration
Sales
E-commerce
HR
Analytics and Tracking
Widgets
Complianz
WPForms
WP Rocket
MonsterInsights
Yoast Plugins
Slider Revolution
Font Awesome
Wordpress Plugins
Google Font API
Contact Form 7
Sitelinks Search Box
Cookie Consent by Osano
Silktide Cookie Consent
reCAPTCHA
Elementor
Wordfence
Google Tag Manager
Mailjet Email Marketing for Wordpress
US Privacy User Signal Mechanism
CrUX Dataset